JP2025527694A5 - - Google Patents
Info
- Publication number
- JP2025527694A5 JP2025527694A5 JP2025511613A JP2025511613A JP2025527694A5 JP 2025527694 A5 JP2025527694 A5 JP 2025527694A5 JP 2025511613 A JP2025511613 A JP 2025511613A JP 2025511613 A JP2025511613 A JP 2025511613A JP 2025527694 A5 JP2025527694 A5 JP 2025527694A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- protein
- protein complex
- invariant region
- polypeptide
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR20220105643 | 2022-08-23 | ||
| KR10-2022-0105643 | 2022-08-23 | ||
| KR20230057361 | 2023-05-02 | ||
| KR10-2023-0057361 | 2023-05-02 | ||
| PCT/KR2023/012348 WO2024043643A1 (ko) | 2022-08-23 | 2023-08-21 | Il2 변이체 및 이를 포함하는 단백질 복합체 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025527694A JP2025527694A (ja) | 2025-08-22 |
| JP2025527694A5 true JP2025527694A5 (enExample) | 2025-09-19 |
Family
ID=90013668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025511613A Pending JP2025527694A (ja) | 2022-08-23 | 2023-08-21 | Ｉｌ２変異体及びそれを含むタンパク質複合体 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP4578871A4 (enExample) |
| JP (1) | JP2025527694A (enExample) |
| KR (1) | KR102655850B1 (enExample) |
| CN (1) | CN119790064A (enExample) |
| AU (1) | AU2023330441A1 (enExample) |
| WO (1) | WO2024043643A1 (enExample) |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20070003934A (ko) * | 2004-03-05 | 2007-01-05 | 노바티스 백신즈 앤드 다이아그노스틱스 인코포레이티드 | 치료제의 환자 내약성을 예측하기 위한 시험관 내 테스트시스템 |
| WO2009061853A2 (en) * | 2007-11-05 | 2009-05-14 | Massachusetts Institute Of Technology | Mutant interleukin-2 (il-2) polypeptides |
| JP6351572B2 (ja) * | 2012-05-10 | 2018-07-04 | ザイムワークス，インコーポレイテッド | Ｆｃドメインに突然変異を有する免疫グロブリン重鎖のヘテロ多量体構築物 |
| ES2774380T3 (es) * | 2014-08-29 | 2020-07-20 | Hoffmann La Roche | Politerapia de inmunocitocinas de variante de IL-2 dirigida a tumor y anticuerpos frente a PD-L1 humano |
| US11053293B2 (en) * | 2016-02-05 | 2021-07-06 | Washington University | Compositions and methods for targeted cytokine delivery |
| US10858428B2 (en) * | 2016-09-28 | 2020-12-08 | Xoma (Us) Llc | Antibodies that bind interleukin-2 and uses thereof |
| SG10201913263SA (en) * | 2016-09-29 | 2020-03-30 | Beijing Hanmi Pharmaceutical Co Ltd | Heterodimeric immunoglobulin constructs and preparation methods thereof |
| CU24483B1 (es) * | 2016-11-15 | 2020-04-02 | Ct Inmunologia Molecular | Método para incrementar los niveles de secreción de la interleucina-2 |
| KR102461885B1 (ko) * | 2017-04-03 | 2022-11-03 | 에프. 호프만-라 로슈 아게 | 항-pd-1 항체와 돌연변이 il-2 또는 il-15의 면역접합체 |
| JP7765181B2 (ja) * | 2017-12-19 | 2025-11-06 | ゼンコア インコーポレイテッド | 改変されたｉｌ－２ ｆｃ融合タンパク質 |
| CA3098930A1 (en) * | 2018-09-21 | 2020-03-26 | Innovent Biologics (Suzhou) Co., Ltd. | Novel interleukin-2 and use thereof |
| AU2020372429A1 (en) | 2019-10-25 | 2022-04-28 | Audentes Therapeutics, Inc. | Compositions and methods for treating glycogen storage disorders |
| KR102559355B1 (ko) * | 2020-01-31 | 2023-07-25 | 주식회사 제넥신 | 항-taa 항체, 항-pd-l1 항체 및 il-2를 포함하는 융합단백질 및 이의 용도 |
| AR121713A1 (es) * | 2020-03-31 | 2022-06-29 | Hanmi Pharm Ind Co Ltd | Nuevos análogos de il-2 inmunoestimulantes |
| US20230295394A1 (en) | 2020-08-26 | 2023-09-21 | Reventas Limited | Improvements In Or Relating To Plastic Recycling |
-
2023
- 2023-08-21 CN CN202380061464.0A patent/CN119790064A/zh active Pending
- 2023-08-21 EP EP23857675.5A patent/EP4578871A4/en active Pending
- 2023-08-21 WO PCT/KR2023/012348 patent/WO2024043643A1/ko not_active Ceased
- 2023-08-21 AU AU2023330441A patent/AU2023330441A1/en active Pending
- 2023-08-21 JP JP2025511613A patent/JP2025527694A/ja active Pending
- 2023-08-21 KR KR1020230109266A patent/KR102655850B1/ko active Active
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20220324931A1 (en) | FUSION PROTEINS COMPRISING A BINDING PROTEIN AND AN INTERLEUKIN-15 POLYPEPTIDE HAVING A REDUCED AFFINITY FOR IL15Ra AND THERAPEUTIC USES THEREOF | |
| JP2022105558A (ja) | 新規のポリペプチド | |
| JP6783797B2 (ja) | 抗がん融合ポリペプチド | |
| CN113226472A (zh) | 双免疫细胞衔接物 | |
| US20220098274A1 (en) | Engineered pd-1 variants | |
| JP2017521998A (ja) | 新規多重特異性分子及びかかる多重特異性分子に基づく新規治療方法 | |
| JP2026053343A (ja) | 加齢性および炎症性疾患を治療する方法 | |
| JP2024521405A5 (enExample) | ||
| CN105408356A (zh) | 双特异性构建体及其用于治疗多种疾病的用途 | |
| CN116981470A (zh) | T细胞调节多肽和其使用方法 | |
| JP2019058160A (ja) | ヒトｐ１８５及び血管内皮増殖因子の両方を標的とする抗体及びその適用 | |
| CN113646328A (zh) | 一种免疫细胞因子及其制备与用途 | |
| US20260085113A1 (en) | All-in-one agonistic antibodies | |
| US20130165629A1 (en) | Bispecific t-cell activator antibody | |
| JP2023541996A (ja) | ＳＩＲＰ１αキメラタンパク質の臨床投与 | |
| JP2023527621A5 (enExample) | ||
| CN118946587A (zh) | 抗pd-1单克隆抗体及其衍生物和用途 | |
| CN113667004A (zh) | 一种白介素2突变体 | |
| WO2022200478A1 (en) | Tumor treatment with a 4-1bb/her2-bispecific agent and a her2-targeted tyrosine kinase inhibitor | |
| CN121646609A (zh) | Tnf超家族成员免疫细胞因子及其用途 | |
| JP2026515642A (ja) | アゴニスト性スプリット抗体 | |
| Fellermeier-Kopf et al. | Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans | |
| JP2023546269A (ja) | Ｔ細胞を増殖させるための二重特異性コンストラクトおよび関連する方法 | |
| CN118255899A (zh) | 一种IL2-IL2Rα异源复合物蛋白及其衍生物 | |
| Barragan-Galvez et al. | Prokaryotic expression of the immunoglobulin’s domains of CRTAM to characterize a monoclonal antibody |